癌症护理市场的基因组学份额，规模，趋势和行业分析报告，产品类型（耗材，仪器，服务）;必威开户注册通过技术，通过申请;结束使用;按地区：分部预测，2019年 - 2025年
- 发布日期：2019年3月
- 第113页：113
- Format: PDF
- Report ID: PM1607
- 基数：2018年
- Historical Data: 2015-2017
Report Summary
The global genomics in cancer care market size was valued at USD 4,701.1 million in 2018 and is anticipated to grow at a CAGR of 17.7% between 2019 and 2025. Genomics in cancer care can be defined as the promising technique for accurate diagnosis of cancer by focusing on advancing personalized medicine. This technology has helped in making systematic assessments for effecting and cost-effective treatment of cancer in the coming years. The field of cancer genomics is a relatively new research area that takes advantage of recent technological advances to study the human genome, meaning our full set of DNAs. By sequencing the DNA and RNA of cancer cells and comparing the sequences to normal tissue such as blood, scientists identify genetic differences that may cause cancer.
癌症护理行业的全球基因组学主要是由于越来越多的患者患者患有癌症的患者，以及创新新型技术的持续技术进步。此外，需要具有成本效益的技术和准确诊断癌症在预测期间将推动癌症护理市场的基因组。此外，在研究实验室和机构中加强了这些技术，以及克服某些缺点的技术创新将在预测期间增加特定市场的增长。
Know more about this report:请求示例页面
Genome sequencing is observing a remarkable growth owing to increasing usage of genomics and technological advancement with modern device and services. As a conclusion, growing demand for effective output with low cost treatment is augmenting the genomic penetration rate in this market. PCR and microarrays are also perceiving swift development in genomics owing to introduction of advanced devices as such devices are used to accomplish genomics procedure and are highly essential component in the target ailment market. Additionally, microarrays are used to measure an analyte present in the body tissues and blood which is further anticipated to generate lucrative growth opportunities in the industry. Moreover, consumables such as reagents, sample preparation kits, and biomarkers are widely used in genomics procedures. Thus, increasing use of consumables are also expected to increase due to vital applications in target disease management.
细分分析
癌症护理市场的全球基因组学分段为产品类型，应用，技术和最终使用。在产品类型的基础上，全球市场是亚被分割成耗材，仪器和服务。必威开户注册仪器分部将拥有主要市场份额的主要市场份额增加，以增加各种PCR仪器中的增长数字化以分析基因组测序。虽然，在基因组学市场中的消费量被观察到在预测期间是增长最快的部分。
基于技术，市场是亚分段为基因组测序，PCR，微阵列核酸提取和纯化。由于准确的诊断和经济高效的治疗，基因组测序持有市场的主要份额。类似地，该技术有助于发现新型药物，例如单核苷酸变体（SNV），结构变体和拷贝数变化。此外，越来越多地利用这种技术，用于诊断癌症，与技术进步有关的数量。还观察到，在预测期间是一种灵活，经济效益，灵活的驾驶基因组测序段市场市场。
在申请的基础上，全球基因组学市场被分段为诊断，个性化药物，药物交付和研究。观察诊断部门以早期癌症诊断需求的不断增长的速度更快，并对癌症护理的基因组学的认识不起作用。另一方面，根据个人免疫力发展新型药物的研究和开发将促进预测期间个性化医学段的增长。
Research institute is the largest segment as an end user for the market, and would hold dominating position during the forecast period. The growth of genomics market in cancer care is primarily driven by the need for accurate screening techniques that gives to the point diagnosis of cancer.
Genomics in Cancer Care Market Scope
By Product |
通过技术 |
通过申请 |
By End-use |
按地区 |
|
|
|
|
|
Know more about this report:请求示例页面
区域分析
通过地理，全球市场被分成五个主要地区，北美，欧洲，亚太地区，拉丁美洲和中东和非洲。北美进一步分段为美国和加拿大。欧洲分为德国，英国，法国，意大利，西班牙，比利时，俄罗斯，荷兰和欧洲其他地区。亚太地区分叉进入中国，印度，日本，韩国，新加坡，马来西亚，印度尼西亚，泰国，菲律宾和亚太地区的其他地方。
In terms of geography, North America dominates the entire market for genomics in cancer care. The growth in North America is primarily driven by the increasing number of patients suffering from cancer, increasing government & biopharmaceutical company funding for developing new drugs, and presence of key players in this region. The North America genomics in cancer care industry is estimated to share approximately 38.4% market share in terms of revenue.
On the other hand, Asia Pacific is considered to grow at a faster rate owning to the developing healthcare infrastructures by the countries such as India, and China. Additionally, improved healthcare infrastructure, continuous government support, and untapped market opportunities have further generated significant market opportunities to the APAC market.
根据癌症基因组的完全研究，在单一类型的癌症中发现了遗传偏差的巨大品种，因此，罕见的遗传修饰发现是基因组学领域的挑战。此外，另一个主要挑战是获得最优质的生物样本，这对于基因组培训以及研究至关重要，主要用于通过外科手术稀有和治疗的肿瘤。
Competitive Analysis
The major players operating in this industry include Agilent Technologies, Roche Diagnostics, Beckman Coulter, Illumina, Inc., Affymetrix, Cancer Genetic Inc., Bio-Rad Labs, Pacific Bio-science, Sigma Aldrich Corporation, GE Healthcare, Quest Diagnostics, Abbott Laboratories, PerkinElmer, and Luminex. These leading players are introducing innovative products in the market to cater to the growing demand for consumers. Global players are entering new markets in developing regions to expand their customer base, strengthen market presence, and increase their market share in the market industry.
